<bill session="108" type="h" number="2498" updated="2023-01-15T16:33:43Z">
  <state datetime="2003-06-17">REFERRED</state>
  <status>
    <introduced datetime="2003-06-17"/>
  </status>
  <introduced datetime="2003-06-17"/>
  <titles>
    <title type="display">Medicare Extension of Drugs to Seniors (MEDS) Act of 2003</title>
    <title type="official" as="introduced">To amend title XVIII of the Social Security Act to provide a prescription benefit program for all Medicare beneficiaries.</title>
    <title type="short" as="introduced">Medicare Extension of Drugs to Seniors (MEDS) Act of 2003</title>
  </titles>
  <sponsor bioguide_id="S000033"/>
  <cosponsors>
    <cosponsor bioguide_id="B001230" joined="2003-06-17"/>
    <cosponsor bioguide_id="B000911" joined="2003-06-17"/>
    <cosponsor bioguide_id="C000380" joined="2003-06-23"/>
    <cosponsor bioguide_id="C000714" joined="2003-06-17"/>
    <cosponsor bioguide_id="D000096" joined="2003-06-17"/>
    <cosponsor bioguide_id="D000191" joined="2003-06-17"/>
    <cosponsor bioguide_id="F000116" joined="2003-06-17"/>
    <cosponsor bioguide_id="F000339" joined="2003-06-17"/>
    <cosponsor bioguide_id="G000551" joined="2003-07-14"/>
    <cosponsor bioguide_id="H000627" joined="2003-06-17"/>
    <cosponsor bioguide_id="K000172" joined="2003-06-24"/>
    <cosponsor bioguide_id="K000336" joined="2003-06-17"/>
    <cosponsor bioguide_id="L000551" joined="2003-06-17"/>
    <cosponsor bioguide_id="N000002" joined="2003-06-17"/>
    <cosponsor bioguide_id="O000085" joined="2003-06-17"/>
    <cosponsor bioguide_id="O000159" joined="2003-06-19"/>
    <cosponsor bioguide_id="P000149" joined="2003-06-17"/>
    <cosponsor bioguide_id="S000248" joined="2003-06-17"/>
    <cosponsor bioguide_id="W000794" joined="2003-06-17"/>
    <cosponsor bioguide_id="W000792" joined="2003-06-17"/>
    <cosponsor bioguide_id="W000738" joined="2003-06-17"/>
  </cosponsors>
  <actions>
    <action datetime="2003-06-17">
      <text>Introduced in House</text>
    </action>
    <action datetime="2003-06-17" state="REFERRED">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2003-06-17">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2003-07-01">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
    <action datetime="2003-07-02">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSWM" name="House Ways and Means" subcommittee="" activity="Referral"/>
    <committee code="HSWM02" name="House Ways and Means" subcommittee="Health" activity="Referral"/>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referral"/>
    <committee code="HSIF14" name="House Energy and Commerce" subcommittee="Health" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Access to health care"/>
    <term name="Administrative procedure"/>
    <term name="Administrative remedies"/>
    <term name="Ambulatory care"/>
    <term name="Auditing"/>
    <term name="Business records"/>
    <term name="Capitation (Medical care)"/>
    <term name="Catastrophic health insurance"/>
    <term name="Civil Rights and Liberties, Minority Issues"/>
    <term name="Coinsurance"/>
    <term name="Commerce"/>
    <term name="Competitive bidding"/>
    <term name="Congress"/>
    <term name="Congressional investigations"/>
    <term name="Congressional reporting requirements"/>
    <term name="Consumer education"/>
    <term name="Cost control"/>
    <term name="Counterfeiting"/>
    <term name="Crime and Law Enforcement"/>
    <term name="Developed countries"/>
    <term name="Disabled"/>
    <term name="Discrimination in insurance"/>
    <term name="Discrimination in medical care"/>
    <term name="Drug adulteration"/>
    <term name="Drug approvals"/>
    <term name="Drug industry"/>
    <term name="Drug utilization"/>
    <term name="Drugs"/>
    <term name="Executive reorganization"/>
    <term name="Federal aid to research"/>
    <term name="Federal budgets"/>
    <term name="Finance and Financial Sector"/>
    <term name="Fines (Penalties)"/>
    <term name="Foreign Trade and International Finance"/>
    <term name="Fraud"/>
    <term name="Generic drugs"/>
    <term name="Government Operations and Politics"/>
    <term name="Government paperwork"/>
    <term name="Government publicity"/>
    <term name="Government trust funds"/>
    <term name="Governmental investigations"/>
    <term name="Grievance procedures"/>
    <term name="Home care services"/>
    <term name="Housing and Community Development"/>
    <term name="Imports"/>
    <term name="Insurance premiums"/>
    <term name="Intellectual property"/>
    <term name="Intergovernmental fiscal relations"/>
    <term name="Kidney diseases"/>
    <term name="Labeling"/>
    <term name="Law"/>
    <term name="Legislation"/>
    <term name="Licenses"/>
    <term name="Managed care"/>
    <term name="Medicaid"/>
    <term name="Medical economics"/>
    <term name="Medical records"/>
    <term name="Medical research"/>
    <term name="Medically uninsured"/>
    <term name="Medicare"/>
    <term name="Medigap"/>
    <term name="Patents"/>
    <term name="Performance measurement"/>
    <term name="Pharmaceutical research"/>
    <term name="Pharmacies"/>
    <term name="Prescription pricing"/>
    <term name="Price discrimination"/>
    <term name="Quality of care"/>
    <term name="Quality of products"/>
    <term name="Rebates"/>
    <term name="Research and development"/>
    <term name="Retiree health benefits"/>
    <term name="Right of privacy"/>
    <term name="Rural health"/>
    <term name="Science, Technology, Communications"/>
    <term name="Social Welfare"/>
    <term name="Taxation"/>
    <term name="Telephone"/>
    <term name="Terminal care"/>
    <term name="Trade secrets"/>
    <term name="Welfare eligibility"/>
  </subjects>
  <amendments/>
  <summary date="2003-07-29T21:30:43Z" status="Introduced in House">Medicare Extension of Drugs to Seniors (MEDS) Act of 2003 - Amends title XVIII (Medicare) of the Social Security Act (SSA) to add a new part D (Prescription Medicine Benefit for the Aged and Disabled) establishing a voluntary insurance program to provide prescription medicine benefits, including pharmacy services, for eligible individuals (including low-income individuals) who are aged or disabled or have end-stage renal disease, and who elect to enroll during a prescribed period. Provides that the program shall be financed from monthly premium payments by enrollees together with Federal appropriations. Creates the Prescription Medicine Insurance Account within the Federal Supplemental Medical Insurance Trust Fund. Directs the Secretary of Health and Human Services to develop and implement an Employer Incentive Program that encourages employers to provide adequate prescription medicine benefits to retired individuals and maintain such existing benefit programs.

Outlines provisions for substantial reductions in the price of prescription drugs for Medicare beneficiaries.

Amends the Federal Food, Drug, and Cosmetic Act, as amended by the Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2001, with respect to the importation of certain prescription drugs, to revise testing requirements (granting the Secretary certain waiver discretion), and add approved labeling requirements.

Requires the recipient of a patent to make a reasonable pricing agreement with the Secretary (or the Secretary to waive such an agreement in the public interest) if any Federal agency or any non-profit entity: (1) undertakes federally funded health care research and development; and (2) is to convey or provide a patent or other exclusive right to use such research and development for a drug or other health care technology.</summary>
</bill>
